key: cord-0902747-dws9tc5y
authors: Berndt, Anthony J.; Smalley, Tressa N.; Ren, Bijie; Simkovsky, Ryan; Badary, Amr; Sproles, Ashley E.; Fields, Francis J.; Torres-Tiji, Yasin; Heredia, Vanessa; Mayfield, Stephen P.
title: Recombinant production of a functional SARS-CoV-2 spike receptor binding domain in the green algae Chlamydomonas reinhardtii
date: 2021-11-18
journal: PLoS One
DOI: 10.1371/journal.pone.0257089
sha: 274b57e315282b6024aa6cd283156d7ad400bc92
doc_id: 902747
cord_uid: dws9tc5y

Recombinant production of viral proteins can be used to produce vaccine antigens or reagents to identify antibodies in patient serum. Minimally, these proteins must be correctly folded and have appropriate post-translation modifications. Here we report the production of the SARS-CoV-2 spike protein Receptor Binding Domain (RBD) in the green algae Chlamydomonas. RBD fused to a fluorescent reporter protein accumulates as an intact protein when targeted for ER-Golgi retention or secreted from the cell, while a chloroplast localized version is truncated. The ER-retained RBD fusion protein was able to bind the human ACE2 receptor, the host target of SARS-CoV-2, and was specifically out-competed by mammalian cell-produced recombinant RBD, suggesting that the algae produced proteins are sufficiently post-translationally modified to act as authentic SARS-CoV-2 antigens. Because algae can be grown at large scale very inexpensively, this recombinant protein may be a low cost alternative to other expression platforms.

In late 2019 a novel coronavirus was identified in the Wuhan province of China with a genome sequence closely resembling that of the Severe Acute Respiratory Syndrome (SARS) coronavirus identified in 2003. Thus, the novel coronavirus was named SARS-CoV-2. The respiratory disease the virus causes has since been named COVID-19 (COronaVIrus Disease 2019). The virus quickly spread worldwide and was classified as a global pandemic in April of 2020 [1] , and has continued to spread more than a year after its initial identification.

Widespread use of nucleic acid tests that detect the SARS-CoV-2 RNA genome, such as RT-qPCR, have become the standard method to detect viral infection. However, laboratory assays that measure antibody responses and determine seroconversion are not yet comparatively as widely available. While such serological assays are not well suited to detect acute infections, and indeed antibody production lags days behind symptoms and infectiousness, multiple relevant applications exist for such antibody tests as they are one of the best indicators Chlorella vulgaris [28] ; however, evaluation of the functionality of the recombinant RBD at its cognate ACE2 receptor was not determined.

Here we examined the potential of utilizing nuclear transformation in the unicellular green microalgae C. reinhardtii as a production platform for recombinant SARS-CoV-2 spike RBD protein. We have produced stable nuclear genome integration vectors that generate an order of magnitude higher recombinant RBD expression levels compared to previously reported methods in C. reinhardtii and maintain this expression for at least one year after transformation. Three different strategies for recombinant protein production within C. reinhardtii were tested by appending different intracellular localization motifs to the transgene. The RBD proteins were targeted to be retained in the Endoplasmic Reticulum-Golgi pathway, secreted out of the cell into the culture media, or targeted for accumulation within the chloroplast. We found that recombinant RBD targeted to the chloroplast accumulated to high levels, but appeared to be truncated by~5 kDa at the amine end of the mature protein, and this protein was not recognized by anti-RBD antibodies in Western Blotting assays. RBD proteins targeted to the ER or secreted from the cell produced a protein of the expected size and correct amino acid sequence. We purified spike RBD protein from the ER-Golgi retained version and demonstrated that it specifically binds to recombinant ACE2 protein at a similar affinity as mammalian expressed RBD. These data demonstrate the potential of using eukaryotic algae as an efficient and scalable platform to make correctly folded and functional SARS-CoV-2 RBD recombinant proteins that could be used in large scale antibody assays or as potential vaccine antigens.

Based on previous studies, as well as bioinformatics and structural modeling, we elected to produce amino acids 319-537 of the SARS-CoV-2 spike protein comprising the RBD [29] ( Fig  1A) . For high throughput screening to rapidly identify recombinant protein production, we fused this domain to the N-terminus of the green fluorescent protein (GFP) derivative mClover [30] . The C. reinhardtii nuclear genome codon optimized fusion genes of the spike-RBD and mClover were then placed in a modified expression vector based on components of the previously published pBR9 and pOpt vectors [26, 31] (Fig 1B) . Expression was driven with the semi-synthetic AR1 promoter [23] . A 5' Bleomycin resistance gene (Ble R ) was included as part of the expression cistron to allow for selection of high expressing clones on Zeocin containing media, while a Foot-and-mouth disease virus 2A ribosomal-skip motif was placed between the Ble R coding region and the RBD::mClover fusion protein, so that the RBD::mClover accumulated as a single fusion protein [23] . A separate Hygromycin resistance gene driven by a betatubulin promoter was placed 3' of the RBD transgene to allow for double selection (Zeocin and Hygromycin), ensuring that the RBD::mClover transgene is intact in any transformant selected [32] .

of the RBD fusion protein, and 3) an ER-Gogli retained version produced by the addition of a C-terminal KDEL retention motif to the carboxy end of the RBD fusion protein containing the PHC2 secretion peptide (Fig 1B) .

The three vectors were linearized and transformed separately into algae via electroporation. Following overnight recovery in complete liquid media, cells were selected on media containing both Zeocin and Hygromycin. Ten days post-transformation, individual colonies were picked into 96-well microtiter plates containing TAP media and grown for two days. The clones were then passaged at a 1:4 dilution in to fresh TAP media for two days and fluorescence analysis, using a plate reader, was used to identify strains with high mClover expression ( Fig 1C) . The mClover fluorescence signal was normalized to chlorophyll fluorescence and compared to both the CC124 starting strain and a previously characterized GFP-expressing strain [33] . Several hundred mClover expressing transformants were recovered for both the secreted and ER retained constructs, from three independent transformations, while only a few dozen colonies were recovered for the chloroplast targeted construct, despite the same amount of DNA being used in each of the transformations. Similarly, by mClover fluorescence analysis, 10-30% of all secreted and ER retained transformants showed fluorescence well A C. reinhardtii nuclear codon optimized version of the RBD-coding sequence was cloned in to a vector containing the AR1 promoter (P AR1 ) driving a transcriptional fusion of the Bleomycin resistance gene (Ble R ), Foot-and-mouth disease virus 2A (F2A) ribosomal-skip motif and 5' mClover green fluorescent protein tag. A separate Beta-tubulin2 promoter driving Hygromycin resistance was used for secondary selection. Three different versions of the RBD were generated. A chloroplast-directed version through Nterminal fusion of the PsaE chloroplast transit sequence, a secreted version by the addition of the PHC2 secretion signal peptide, and an ER-Golgi system retained version by the subsequent addition of a C-terminal KDEL Golgi retention sequence. (C) Schematic summarizing transformation process and timeline including drug selection, clone down selection through 96-well microtiter plates, and then flask-scale characterization of candidate RBD-expressing lines.

https://doi.org/10.1371/journal.pone.0257089.g001

SARS-CoV-2 spike RBD expressed in algae above wild type, while only about 1-5% of the chloroplast-directed strains showed any mClover fluorescence.

When characterized by SDS-PAGE followed by Western Blotting using anti-GFP antibodies to detect the mClover tag, we found cell pellets of the secreted and ER retained versions of the RBD::mClover protein generated a band at the expected molecular weight of~51 kDa. Similarly, ammonium sulfate precipitated protein from the media of the RBD::mClover secreted construct had a detectable band at~51 kDa. Of the few recoverable Chloroplast-directed RBD::mClover transformants, all showed a smaller anti-GFP immunoreactive product at~45 kDa, clearly smaller than the expected 51 kDa product (Fig 2A) . Further characterization using anti-SARS-CoV-2 RBD polyclonal antibodies to probe the Western Blots, revealed that while 

SARS-CoV-2 spike RBD expressed in algae the secreted and ER-Golgi retained proteins were detected as expected 51 kDa bands, the chloroplast directed proteins at~45 kDa were not detected, despite generating comparatively stronger anti-GFP signal ( Fig 2B) . It should be noted that a weak cross-reactive band at~51 kDa is observed in the wild-type algae lysate when blots are probed with the anti-RBD Rabbit Polyclonal antibody. When equal amounts of total cell lysate protein were loaded, darker bands were observed in lysates from the ER-Golgi retained and secreted RBD::mClover strains at the expected molecular weight compared to either the wild type or Chloroplast directed strain (S1 Fig for loading control verification using anti-AtpB).

The chloroplast localized RBD::mClover protein was then purified using anion exchange chromatography followed by anti-GFP magnetic bead immunoprecipitation, and the partially purified protein products were characterized using protein mass spectrometry analysis. The most N-terminal peptide fragment detectable by mass spectrometry in the chloroplast-directed RBD::mClover corresponded to a protein product that would be 9 kDa smaller than the predicted 51 kDa full length mature protein, while a parallel experiment using the ER-Golgi retained protein identified peptide matches across the entire length of the protein (S2 Fig). Additionally, multiple mass spectrometry peptide matches cover the entirety of the C-terminal mClover domain of the Chloroplast-directed version further suggesting the truncation is in the N-terminal region. We PCR-amplified and sequenced the chloroplast localized and ER-Golgi retained versions of the transgenes in the algal transformants to confirm that the truncation of the chloroplast-localized RBD::mClover was not due to a mutation in the integrated nuclear transgene. In both cases, a perfect match to the designed reference sequence was found throughout the RBD::mClover coding region.

To further help down-select and characterize our recombinant RBD constructs, we conducted fluorescence microscopy on live mounted cells. Obvious subcellular localization of mClover fluorescence to the vesicles and the ER-Golgi system is observed in both our secreted and ER-Golgi retained recombinant constructs (Fig 2C-2R) . Comparatively, the chloroplastdirected version displays diffuse fluorescence throughout the cell and little co-localization with the Chlorophyll auto-fluorescence of the chloroplast itself (Fig 2G-2J) . Collectively, the mislocalization and truncation of the chlorophyll-directed version of recombinant RBD::mClover led us to down-select against this version for further characterization.

To characterize the RBD protein produced using C. reinhardtii, we opted to purify the RBD:: mClover from the ER-retained version rather the secreted version, because we noticed that the protein had similar molecular mass, suggesting similar post-translational modifications. Additionally high molecular weight aggregates and low molecular weight degradation products were observed in the precipitated secreted proteins; thus, making the ER-retained version the most optimal option of our three constructs (Fig 2B) . Using a variety of chromatography resins (Fig  3) , we were able to purify sufficient amount of ER-retained RBD::mClover to characterize the protein for receptor-interaction activity. We found that total RBD::mClover protein was 2.6% of total protein after this partial purification with a starting concentration of~0.1% total soluble protein using our extraction method. We determined initial recombinant protein yields of 31 μg/gram of total wet biomass and, after partial purification, 1.8 μg/gram of total wet biomass.

The SARS-CoV-2 spike RBD interacts with human host cells through ACE2 receptor binding [4, 6, 29] . To determine if the algae-expressed ER-retained RBD::mClover was correctly folded and functional, we established a human ACE2 receptor binding assay for SARS-CoV-2 RBDcontaining proteins. HEK cell line expressed biotinylated soluble human ACE2 receptor was immobilized on Strepavidin coated microtiter plates and used as a substrate for SARS-CoV-2 RBD binding. To validate the assay we first determined that the HEK cell expressed SARS--CoV-2 RBD C-terminally fused to rabbit IgG Fc (RBD::rFc) could bind to the immobilized ACE2, and could identify that the recombinant RBD bound the ACE2 protein at an EC 50 of 36 nM (Fig 4A) . This affinity is within the nM range previously reported for SARS-CoV-2 RBD-ACE2 interactions [34, 35] . Next we added a constant amount of our partially purified 

SARS-CoV-2 spike RBD expressed in algae algae-expressed RBD::mClover (40 nM) to each ACE2 receptor coated well, and then titrated in RBD::rFc as a competitor. Using anti-GFP antibodies to detect RBD::mClover bound to the immobilized ACE2 receptor, we find that the RBD::rFc will compete RBD::mClover binding at the ACE2 receptor with an IC 50 of~20 nM. Since a roughly equal concentration of HEK cellproduced RBD::rFc, compared to the RBD::mClover, is required to generate~50% competition at the ACE2 receptor, we suggest that this indicates that the algae-produced RBD displays a similar affinity for the receptor as the mammalian produced version. Further, this competition appears to be specific because addition of Bovine Serum Albumin as a potential competitor does not decrease apparent RBD::mClover binding (Fig 4B) .

Here we have demonstrated that production of a correctly folded and functional SARS-CoV-2 spike protein Receptor Binding Domain is possible in the green alga C. reinhardtii. By fusing the viral protein to a fluorescent mClover protein, we could use a high throughput fluorescent screening strategy to rapidly identify strains of algae expressing sufficient quantities of SARS--CoV2 RBD to test protein accumulation and function. We showed that stably integrated nuclear encoded transgenes, directed to either the ER or secreted from the cell, produce a fusion protein of the expected size that appeared to be correctly folded and post-translationally modified, allowing the protein to specifically bind the ACE2 receptor. Using partially purified ER localized algae SARS-CoV-2 RBD to conduct ACE2 receptor binding interaction assays, we demonstrated that the algae-produced ER-retained version of RBD::mClover did indeed interact in a specific manner with its cognate human host receptor, at a perceived affinity similar to mammalian cell line expressed SARS-CoV-2 RBD, suggesting that the folding and posttranslational modifications of the recombinant algae RBD are sufficient to mediate appropriate RBD binding activity. Although seeming to be expressed at higher levels, the RBD protein targeted to the chloroplast appeared to be truncated. We reason that the truncation is occurring at the N-terminus because a loss of~5 kDa from the C-terminus would eliminate multiple beta-sheets from the mClover beta-barrel thus abrogating fluorescence; yet, we can readily detect mClover fluorescence under the microscope and using a microtiter plate reader. Lack of mass spectrometry peptide matches in the N-terminus of the chloroplast-directed version but strong coverage of the mClover C-terminal supports this. The truncation itself may be occurring before chloroplast translocation because the mClover fluorescence observed under the microscope did not localize well with the chlorophyll auto-fluorescence.

Collectively these data demonstrate the suitability of algae as a platform for the rapid production of recombinant proteins that are correctly folded and post-translationally modified to create a functional protein. Because algae can be grown at scale for a fraction of the cost of mammalian cell lines, this system offers the potential to produce this recombinant viral protein for a variety of uses including as an antigen to detect serum antibodies against SARS-CoV-2 RBD or even as a potential viral antigen for vaccine development, in a rapid and cost-effective manner.

Recently SARS-CoV-2 RBD has been reported to be produced in other photosynthetic systems. SARS-CoV-2 RBD has been transiently expressed in N. benthamiana by agroinfiltration of Agrobacterium carrying recombinant expression vectors with a reported yield of 8μg/gram leaf mass of highly purified recombinant RBD able to bind to the ACE2 receptor (compared to our 31 μg/gram wet biomass of unpurified RBD and 1.8 μg/gram wet biomass of partially purified RBD). Of note, the N. benthamiana RBD expression construct used a C-terminal 8xHis tag to enable Ni-NTA affinity resin purification from relatively crude leaf extract [20] . A similar His-tagged transgene design could be adopted to facilitate more efficient and rapid purification of RBD and other recombinant proteins from C. reinhardtii since protein purification from land plants and algae face similar problems of heavy cell wall debris and pigment loads that make many conventional purification workflows developed for bacteria, yeast, or mammalian cells often untenable. In the current study, we needed to develop a novel de-fatting/decolorization and clarification method to avoid irreversible fouling of our protein chromatography columns and loss of resolution during chromatographic separation.

Transient expression of SARS-CoV-2 RBD in both C. reinhardtii and C. vulgaris at 1-2 μg/ gram total wet biomass was recently reported using an Agrobacterium-mediated transformation method and vectors adapted directly from N. benthamiana [28] . In these transiently transformed algae, receptor binding activity was not assessed, nor was the long term expression levels of the protein beyond 72 hrs post-transformation characterized. Comparatively our expression method involves nuclear genome integration with transformants that have stably expressed the RBD transgene without obvious attenuation for approximately one year at the time of this publication. Moreover, this nuclear transformation method generates an order of magnitude higher expression level of RBD::mClover per gram of wet biomass in C. reinhardtii and only takes three weeks from transformation to initial transformant characterization by Western Blotting. The higher expression level likely stems from the combined use of initial Zeocin antibiotic resistance selection (i.e. the resistance gene stoichiometrically sequesters rather than degrades Zeocin) followed by a fluorescence-based down-selection method for primary nuclear genome transformants as well as the use of endogenous promoters, untranslated regions, and a codonoptimized RBD sequence. Use of stronger endogenous or synthetic promoters [36] in new transgene designs as well as the addition of more introns [37] in to the RBD-coding sequence could be used to boost recombinant RBD expression from the nuclear genome in future optimized expression constructs. Further improvements on recombinant RBD expression can be made through mating and mutagenesis followed by high throughput selection methods such as flow cytometry since our RBD transgene contains a fluorescent protein tag. Previously, our group demonstrated a 15-fold improvement in a chloroplast encoded transgene through such an approach over just a few months of crossing, mutagenesis, and selection [33] . Transformation of the C. reinhardtii chloroplast genome could be attempted as an alternative strategy since markedly higher recombinant transgene expression levels have been reported from constructs integrated in to the plastid genome [38, 39] . However, it should be noted, that many of the chloroplast genome engineering approaches in C. reinhardtii that generate the highest transgene expression levels also attenuate or eliminate the photosynthetic ability of the organism, thus removing the option of low cost photosynthetic cultivation [38, 40] .

To enable large scale photosynthetic production of recombinant proteins and to drive down production costs, reliable long-term expression from well characterized strains will be required to avoid both batch variation and the need to constantly re-transform the system. While transient expression of SARS-CoV-2 antigens may be more facile in N. benthamiana, stable nuclear genome integration and overall productivity in C. reinhardtii or closely related species may be superior if we consider daily productivity of algal systems under photosynthetic conditions compared to land plants. When projecting commercial scale production of microalgae in large open ponds, typical productivities range from 40-80 Mg/ha/yr at a cost of approximately $2,000/Mg whole cell dry biomass [41] [42] [43] . In comparison, tobacco plants typically yield 2.5-5 Mg/ha/yr [44] , potentially resulting in more than a ten-fold increase in biomass productivity when using microalgae as a production platform. It has also been shown that C. reinhardtii is capable of being grown using industrial fermentation processes, producing approximately 200 mg/L/hr of biomass [22, 45] . Assuming that the nuclear encoded transgene design can be further improved and coupled with breeding to generate an expression strain generating 1% total soluble protein as recombinant RBD, upwards of 400 kg/ha/yr of RBD at annual production cost of $80,000 could be achieved. This excludes the cost of downstream biomass processing and purification. With this considered, other expression systems currently display more facile protein purification than green algae does and further improvements will be required to fully realize the potential of green algae as a recombinant protein production platform.

In light of multiple new SARS-CoV-2 variants containing mutations in the spike RBD that correlate with the strains being more transmissible and/or displaying immune system evasion [46, 47] , developing rapidly engineered and scalable expression systems will remain vital despite the roll out of vaccines. For example, serology assays that specifically detect immunity to new variants or booster vaccines against such variants will be key tools as the COVID19 pandemic stretches in to the 2020s. To this end, it would be interesting to apply the rapid but transient agrobacterium mediated transformation approaches to rapidly advance through design-build-test cycles on multiple variations of RBD transgene constructs, such as testing variations of affinity tags or additional subcellular localization approaches, and then apply those lessons to stable integration methods for scale-up.

Chlamydomonas reinhardtii strain CC124 was used throughout experiments. Cells were grown on standard TAP media [48] under 24-hr light conditions at~22-25˚C at a photon flux of 125 μE/m 2 /sec on shaker tables rotating at 110 RPM.

The genomic sequence of SARS-CoV-2 (Wuhan-Hu-1 strain) was retrieved from the NCBI (NC_045512). Amino acids 319 to 542 of the spike protein comprising the RBD were codon optimized for C. reinhardtii nuclear genes [49] . Briefly, we generated a codon-usage table using the mRNA sequences derived from the top 1600 (~10%) nuclear genes expressed in C. reinhardtii in TAP media under light growth conditions [50] . Codon optimization was then performed using Unipro UGENE [51] with final codon rotations to avoid direct repeats or regions of >70% GC content that were flagged as difficult to synthesize by the IDT gBlock design tool. The full codon optimized sequence was synthetized as a double-stranded gBlock oligonucleotide by IDT (Integrated DNA Technologies Coralville, IA).

The expression vector was derived from previously published pBR9 [26] , pOPT mClover [31] and pHyg3 [32] . Standard PCR-based amplification to add overlap-adaptors and Gibson-style assembly methods (HiFi Assembly Kit, New England Biolabs, Ipswich, Massachusetts) were used to assemble the final vectors. The entirety of the C. reinhardtii-specific payload was sequenced by Sanger Method at Eton Bioscience (San Diego, CA).

After examining available structures of the SARS-CoV-2 S-protein, a slightly smaller version of the RBD, comprising amino acids 319-537, was chosen for further subcloning to avoid a cysteine that is normally in a disulfide bridge with the "stalk" of the S-protein and may pose potential stability or intermolecular dimerization issues. Three different sub-cellular localization strategies were chosen for RBD expression. First, a chloroplast-localized version was produced by N-terminal fusion of a previously characterized psaE chloroplast transit sequence localization signal [52] to the RBD domain generating vector pRMC1. The genomic sequence spanning the psaE start codon until four amino-acids after the CTS cleavage site were amplified from C. reinhardtii strain CC125 genomic DNA purified by standard Phenol/Chloroform/SDS lysis and Isopropanol/Ethanol precipitation method. The second construct contained a secretion peptide motif (as predicted by SignalP5.0) from the Pherophorin 2 gene (PHC2) [53] . The signal peptide was specifically chosen because PHC2 is known to be highly abundant in the C. reinhardtii secretome [54] . The genomic locus was amplified and placed upstream of the RBD coding sequence, as indicated above for the psaE CTS, to generate vector pRMC2. Finally, an ER-Golgi retained version of the RBD was generated by adding an additional KDEL retention motif to the C-terminus of the RBD coding sequence in pRMC2 to generate pRMC3. All vector maps are included as GenBank files in S2 File.

All plasmid vectors were prepared by Qiagen midi prep and 10-20 ug of DNA linearized by digest with KpnI-HF and XbaI restriction enzymes at 37˚C in NEB Cutsmart buffer with enough units of activity to generate~5X overdigest in two hours (New England Biolabs, Ipswich, MA). Reaction was stopped and DNA partially purified by NaCl/Isopropanol precipitation followed by three 70% Ethanol washes and resuspension in 1 mM Tris-HCl, 0.1 mM EDTA overnight at 4˚C.

A starter culture of C. reinhardti strain CC124 was grown in standard TAP media to near saturation (~3x10 6 cells/mL) then diluted back in to 0.25x10 6 cells/mL in 300 mL of TAP media in a baffled flask~24 hours before transformation. The next day, cells were collected at a density of 0.75-1.0x10 6 cells/mL by centrifugation at 3000 rcf x 10 minutes at 16˚C in sterile disposable conical bottom centrifuge bottles. The cells were then resuspended in GeneArt1 MAX Efficiency1 Transformation Reagent for Algae (Thermo Scientific, Waltham, MA) and processed according to manufacturer's instructions. Each construct was electroporated using a Gene Pulser Xcell Electroporation System (Bio-Rad Laboratories, Hercules, CA) with 2 ug of linearized vector DNA. After over-night recovery in 40 mM Sucrose in TAP media, cells were pelleted, resuspended in 5 mL of fresh TAP media and 200 uL of cells were spread on 10 cm diameter plates containing 15 μg/mL Zeocin and 30 μg/mL Hygromycin B (Thermo Scientific, Waltham, MA) in TAP+15 g/L agar media.

Ten days after electroporation, individual colonies were transferred into 96-well microtiter plates containing liquid TAP media; CC124 strain and previously generated GFP-expressing strain [33] were included in each plate as internal positive and negative controls. mClover fluorescence, chlorophyll fluorescence, and optical density were quantified following previously published methods [33] ; mClover fluorescence was normalized to chlorophyll to account for differences in cell density. The seven highest normalized mClover fluorescence clones were then inoculated into 50 mL shaker cultures, and grown for three days until late log phase was achieved (1-3x10 6 cells/mL), at which point one mL of culture was harvested for further analysis. For pRMC1 and pRMC3 the supernatant was aspirated off and the pellet was snap frozen at -70˚C. For pRMC2 the 50 mL of supernatant was recovered, centrifuged a second time to remove any residual cell debris, and then 40 mL of culture media snap frozen. Subsequently, secreted RBD::mClover was precipitated by addition of solid ammonium sulfate to a final concentration of 302 g/L (~50% saturation at 0˚C), followed by incubation over night at 4˚C with mixing, then centrifugation at 16x10 3 rcf. The supernatant was removed and the pellet was resuspended in 200 μL of 50 mM Tris-HCl pH 8.5. In preparation for Western Blot analysis, cell pellets were quick thawed in a room temperature water bath, lysed in 100 μL of Bugbuster (Sigma Aldrich, St. Louis, Missouri) for 10 minutes on ice with the addition of Basemuncher (Abcam, Cambridge, MA), cell debris was pelleted (5 minutes x 16x10 3 rcf at 4˚C) and 60 μL of clarified supernatant recovered. Proteins were denatured by addition of 20 μL 4X Laemmli buffer with 10% BME and then heat treated at 80˚C for 10 minutes before 20 μL were loaded on to a Tris-Glycine TGX 12% acrylamide gel for SDS-PAGE (Bio-Rad Laboratories).

After separation on acrylamide gels, proteins were transferred to nitrocellulose membranes via semi-dry transfer (15 V x 60 minutes). Membranes were washed 3x2 minutes with TBSMT (50 mM TrisHCl pH 7.4, 150 mM NaCl, 0.05% Tween-20) then blocked for 20 minutes in Haycock's blocking solution; 1% wt/vol Polyvinylpyrrolidone in TBSMT [55] . Recombinant gene product was either detected with Goat anti-GFP conjugated to Alkaline Phosphatase (ab6661 Abcam, Cambridge, Massachusetts) at 1:5000 dilution or 1:5000 Rabbit Polyclonal anti-SARS-CoV2 RBD (Cat# 40592-T62 Sino Biological, Chesterbrook, PA), in Haycock blocking solution. The latter was then detected with Goat anti-Rabbit::AP at 1:10,000 dilution. All antibodies were incubated for 60 minutes at room temperature and 4x3 minute washes in TBSMT were conducted between steps. Chromogenic development was performed by BCIP/NBT reaction in Alkaline Phosphatase buffer (100 mM TrisHCl pH 9.5, 5 mM MgSO 4 , 0.01% Tween-20) before quenching the reaction by washing in distilled water followed by TBSMT. For anti-AtpB loading controls in S1 Fig, the above protocol was followed but Rabbit anti-AtpB (Beta subunit of ATP synthase; chloroplastic and mitochondrial; Agrisera, Sweden) was used as the primary antibody at 1:20,000 dilution. For all Coomassie stained gels, proteins were separated by SDS-PAGE as above and then stained with SimplyBlue SafeStain (Thermo Fisher Scientific) as per manufacturer's standard protocol.

Soluble protein was calculated using the Pierce Coomassie (Bradford) Protein Assay Kit (Thermo Fisher Scientific) according to the manufacturer's instructions after lysis with the Bugbuster lysis cocktail. For total soluble protein from lysate, to control for potential confounding detergent effects, an equivalent amount of Bugbuster cocktail was added to the BSA standards. RBD::mClover quantification was done through semi-quantitative Western Blotting using HEK-cell produced RBD::6xHis (Cat# 40592-V08H Sino Biological) as a standard at half-log dilutions from 100 μg/mL to 10 ng/mL. Pseudo-densitometry was then performed using Fiji [56] and the standard curve and linear regression generated in Graphpad Prism 5.0 (GraphPad Software, San Diego, CA). Total soluble protein from lysate and purified protein values are presented as calculations from one sample.

The strains verified above as expressing RBD::mClover were subject to genomic DNA extraction using the Chelex 100 boil method [57] . Primers flanking the transgene (FDX1_seq1 5'-TAGCGCAGCTTCGCCTACAT-3' and BTpro_seq2 5'-AGCTCGAGTGGCCTGTGT AGA-3') were then used to amplify the entirety of the RBD::mClover coding region using Q5 DNA polymerase (New England Biolabs). PCR amplicons were size-verified by electrophoresis on a 0.8% TAE agarose gel stained with SYBR Safe (Thermo Scientific, Waltham, MA) and then excised and purified using the Wizard1 SV Gel and PCR Clean-Up System kit (Promega, Madison, WI) according to manufacturer's protocol. The purified amplicons were then subcloned in to pJet1.2 using the CloneJET PCR Cloning Kit (Thermo Scientific, Waltham, MA) according to manufacturer's protocol and the ligation product transformed in to DH5alpha chemically competent cells (New England Biolabs), miniprepped, and sequenced using primers AJB5_seq1, RBD_seq1, RBD_seq2 and Clov_seq1 (5'-GCAGACCCTGAACTTCG-3', 5'-CCGGCAAGATCGCTGACTAC-3', 5'-GATTGGACTTGCGGAACAGG-3', and 5'-GCT GAACTTGTGGCCGTTC-3', respectively) as well as the kit provided pJet1.2F/R primer pair.

Cells were grown in liquid TAP media without antibiotics to mid-log phase (~1x10 6 cells/mL) on a rotary shaker. Cells were live mounted on conventional microscope slides in TAP media with glass coverslips. Images were captured on a Delta Vision (Applied Precision Inc., Issaquah, WA) optical sectioning microscope system composed of an Olympus IX71 inverted microscope (Center Valley, PA) equipped with an Olympus UPlanSApo 100×/1.40 objective and a CoolSNAP HQ2/ICX285 camera (Photometrics, Tucson, AZ). The Tetramethylrhodamine isothiocyanate (TRITC) filter (EX555/28 and EM617/73) was used to image Chlorophyll auto-fluorescence while the GFP filter (EX470/40 and EM525/36) was used to image mClover fluorescence. Image acquisition was performed using Resolve3D SoftWoRx-Acquire (Version 5.5.1, Applied Precision Inc, Issaquah, WA). Brightness and contrast were adjusted identically across all images using FIJI software.

Algae cultures were grown in a semi-continuous fashion in 1 L baffled flasks in TAP media wherein 95% of the culture was harvested via centrifuge and replaced with new media every two days; harvested call pellets were snap frozen until lysis. Cells were lysed in 1X Bugbuster (diluted from 10X buffer free stock) buffered with 50 mM Tris-HCl pH8.5 containing 1X Pierce Protease Inhibitor Cocktail (Cat#A32955; Thermo Scientific, Waltham, MA), 250 U/ mL of Basemuncher endonuclease (ab270049, Abcam, Cambridge, MA), 1 mM DTT, 1 mM EDTA. 10 mL of lysis buffer was added to each gram of snap frozen wet biomass with typically 3-6 grams of wet biomass being processed at once. To the partially clarified cell lysate 10% wt/ vol Polyethylenimine (Cat#408719, Sigma-Aldrich, St. Louis, MO), adjusted to pH 8.5 by addition of concentrated HCl was added to a final concentration 0.1% wt/vol. The lysate was then centrifuged at 6000 rcf at 4˚C for 5 minutes and supernatant recovered. The lysate was then further decolorized by gently shaking against an equal volume of Methyl tert-Butyl Ether (MTBE) twice and then Hexanes (Fisher Scientific). The aqueous layer was then recovered, filtered through a 0.45 μm PES syringe filter and applied to a Capto Q anion exchange resin for column chromatography purification on an Akta pure 150 system fitted with an external sample pump (Cytiva, Amersham, UK).

A 5 mL HiTrap Capto Q resin anion exchange column (Cytiva) was equilibrated with 5 column volumes (CV) of 50 mM TrisHCl pH8.5. The clarified and decolorized lysate was then applied to the column through the system pump at 3 mL/minute. The column was washed with 10 CV equilibration buffer. The RBD::mClover enriched fraction was eluted with 5 CV of 100 mM NaCl in Tris-HCl pH8.5 buffer. During bulk purification~20 mL of lysate was bound to the column before binding capacity for the RBD was reached. When 40 mL of clarified lysate was processed for bulk purification, 20 mL of lysate was first bound to the column, washed, and eluted as above before the column being immediately stripped by the addition of 5 CV of 1 M NaCl, then 5 CV of 1 M NaOH, before re-equilibrating with 10 CV 50 mM Tris-HCl and performing a second purification cycle. A 5 mL HiTrap Phenyl HP resin prepacked Hydrophobic Interaction column (Cytiva) was equilibrated with 5 column volumes (CV) of 0.4 M (NH 4 ) 2 SO 4 , 50 mM Sodium Phosphate buffer pH 7.4. Immediately after Anion Exchange fractionation, the combined 100 mM NaCl fractions containing the RBD::mClover were brought to 0.4 M (NH 4 ) 2 SO 4 by addition from a 2 M stock solution. The RBD::mClover fraction was then applied to the Phenyl HP resin at a rate of 3 ml/min before being washed with 7.5 CV of 0.35 M (NH 4 ) 2 SO 4 , 50 mM Sodium Phosphate buffer pH 7.4. The bound RBD:: mClover was then eluted by the addition of 5 CV of 0.15 M (NH 4 ) 2 SO 4 , 50 mM Sodium Phosphate buffer pH 7.4. The eluted fraction was then concentrated using Amicon Ultra 15 diaconcentrators with a 10kDa cutoff (Cat # UFC901024, Millipore, Temecula, CA) and buffer exchanged 3 times with PBS pH7,4 (Cat # 10010023 Gibco, Waltham, MA) before concentrating down to 3 mL.

Strepavidin coated microtiter plates (Cat#15124, Thermo Fisher) were washed 3X in Receptor Assay Blocking buffer (25 mM TrisHCl, 150mM NaCl, pH 7.4, 0.1% wt/vol Bovine Serum Albumin, 0.05% vol/vol Tween-20) and then were coated with 50 ng per well of biotylated human ACE2 produced in HEK cells lines (Cat#10108-H08H-B Sino Biological) dissolved in 100 μL of PBS for one hour at room temperature with gentle shaking on an orbital table. HEK cell-produced recombinant SARS-CoV-2 RBD fused C-terminally to rabbit IgG Fc (RBD::rFc, # 40592-V31H Sino Biological) was used as a specific competitor. A dilution series of 100 to 0.01 μg/mL RBD::rFc was made in PBS containing 2 μg/mL of partially purified algae produced ER-Golgi retained RBD::mClover including a no-RBD::rFc reference. As a negative control, Bovine Serum Albumin (Cat# 23209, Thermofisher) was added at the same molar concentrations as RBD::rFc. Wells were washed four times with Receptor Assay Blocking buffer and then filled with the RBD competitor solution at 30 μL/well for 1 hour at room temperature as above. Wells were washed four times and then filled with 100 μL of Goat anti-GFP conjugated to Horseradish Peroxidase (ab6663, Abcam) diluted 1:3000 in Receptor Assay Blocking buffer. After a 30-minute incubation, wells were washed four times and then 100 μL of Pierce TMB substrate kit added. The chromogenic reaction was incubated at room temperature for 20-25 minutes and then quenched with 100 μL of 2 M HCl. The absorption was then measured at 490 nm using a Tecan Infinite m200 Pro plate reader. Receptor-competition assays were performed as three independent experimental runs. The data are represented as the mean A 490 signal normalized to the maximum absorption of each experimental run and variance is represented as the Standard Error of the Mean. Initial confirmation of RBD::rFc binding to the ACE2 receptor was performed as above but by simply adding RBD::rFc at increasing concentrations from 0.01 to 300 ug/mL and detected with 1:3000 Goat anti-Rabbit IgG-HRP (Cat#AP307P, Sigma). A single experimental run is represented in Fig 4. In both experiments, data were plotted using Graphpad Prism. For the initial confirmation of RBD: rFC binding, a one-site total binding non-linear regression was used to calculate the EC 50 .

Protein lysate from the Chloroplast-directed and ER-Golgi Retained strains were prepared as above and RBD protein purified by Anion exchange chromatography using Capto-Q resin. It should be noted that the ER-Golgi retained version of RBD::mClover eluted at 100 mM NaCl in one fraction when a 100 mM stepped gradient from 0 to 500 mM NaCl was tested, while the Chloroplast directed version eluted over a broad range of salt concentrations from 200 to 400 mM NaCl, suggesting marked differences in affinity to the Capto Q anion exchange resin. The RBD::mClover enriched fractions where then diaconcentrated and buffer exchanged three times against 50 mM Tris-HCl, pH 8.5. These samples were then further purified using Anti-GFP mAb-Magnetic Beads (Cat# D153-11, MBL International, Woburn, MA) according to manufacturer's protocol except for washing with 50 mM Tris-HCl pH 8.5 with 0.05% Tween-20. Samples were submitted for mass spectrometry at the University of California, San Diego's Biomolecular and Proteomics Mass Spectrometry Facility as either on-bead digestions or as excised bands from SDS-PAGE gels stained with SimplyBlue Coomassie stain according to manufacturer's instructions (Thermo Scientific). 

WHO Declares COVID-19 a Pandemic

Assay Techniques and Test Development for COVID-19 Diagnosis

SARS-CoV-2 vaccines in development

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

The antigenic anatomy of SARS-CoV-2 receptor binding domain

Potently neutralizing and protective human antibodies against SARS-CoV-2

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

The receptorbinding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

Receptor-binding domain of SARS-Cov spike protein: Soluble expression in E.coli, purification and functional characterization

Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity

Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate

Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine PLOS ONE SARS-CoV-2 spike RBD expressed in algae

Expression of HIV-1 antigens in plants as potential subunit vaccines

Biological and biochemical characterization of HIV-1 Gag/ dgp41 virus-like particles expressed in Nicotiana benthamiana

A Plant-Produced Antigen Elicits Potent Immune Responses against West Nile Virus in Mice

Antigen Production in Plant to Tackle Infectious Diseases Flare Up: The Case of SARS

SARS-CoV-2 Antigens Expressed in Plants Detect Antibody Responses in COVID-19 Patients

Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana

Production of recombinant proteins through sequestration in chloroplasts: a strategy based on nuclear transformation and post-translational protein import

Fed-batch mixotrophic cultivation of Chlamydomonas reinhardtii for high-density cultures

Robust Expression and Secretion of Xylanase1 in Chlamydomonas reinhardtii by Fusion to a Selection Gene and Processing with the FMDV 2A Peptide

Production of therapeutic proteins in algae, analysis of expression of seven human proteins in the chloroplast of Chlamydomonas reinhardtii

Recent advancements in the genetic engineering of microalgae

Expanding the spectral palette of fluorescent proteins for the green microalga Chlamydomonas reinhardtii

Current advances in the algae-made biopharmaceuticals field

Efficient Transient Expression of Recombinant Proteins Using DNA Viral Vectors in Freshwater Microalgal Species

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Improving FRET dynamic range with bright green and red fluorescent proteins

Targeted expression of nuclear transgenes in Chlamydomonas reinhardtii with a versatile, modular vector toolkit

An Engineered Streptomyces hygroscopicus aph 7@ Gene Mediates Dominant Resistance against Hygromycin B in Chlamydomonas reinhardtii

Nuclear genome shuffling significantly increases production of chloroplast-based recombinant protein in Chlamydomonas reinhardtii

RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2

Synthetic promoters capable of driving robust nuclear gene expression in the green alga Chlamydomonas reinhardtii

Introns mediate post-transcriptional enhancement of nuclear gene expression in the green microalga Chlamydomonas reinhardtii

Algae-Produced Pfs25 Elicits Antibodies That Inhibit Malaria Transmission

Factors effecting expression of vaccines in microalgae

Production of recombinant proteins in microalgae at pilot greenhouse scale

A Realistic Technology and Engineering Assessment of Algae Biofuel Production

Techno-economic analysis of autotrophic microalgae for fuel production

Process Design and Economics for the Production of Algal Biomass: Algal Biomass Production in Open Pond Systems and Processing Through Dewatering for Downstream Conversion

Biomass Characteristics and Energy Yields of Tobacco (Nicotiana tabacum L.) Cultivated in Eastern Poland

Efficient heterotrophic cultivation of Chlamydomonas reinhardtii

Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study. The Lancet Public Health

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

Cytochrome f and plastocyanin: their sequence in the photosynthetic electron transport chain of Chlamydomonas reinhardi

A serological assay to detect SARS-CoV-2 seroconversion in humans

Lineage-specific chromatin signatures reveal a regulator of lipid metabolism in microalgae

Unipro UGENE: a unified bioinformatics toolkit

Chloroplast transit peptides from the green alga Chlamydomonas reinhardtii share features with both mitochondrial and higher plant chloroplast presequences

SignalP 5.0 improves signal peptide predictions using deep neural networks

Proteases Shape the Chlamydomonas Secretome: Comparison to Classical Neuropeptide Processing Machinery

Polyvinylpyrrolidone as a Blocking Agent in Immunochemical Studies

Fiji: an open-source platform for biological-image analysis

Rapid and simple method for DNA extraction from plant and algal species suitable for PCR amplification using a chelating resin Chelex 100

The elements of Fig 1 were created